Terrain Bio accelerates RNA medicine development with an AI-driven platform for sequence design and rapid mRNA manufacturing. Their technology optimizes RNA candidates for enhanced manufacturability and therapeutic properties, enabling faster progression from discovery to preclinical studies.
Funding
Funding not disclosed
Founders
Product
Problem
Developing RNA medicines involves navigating complex sequence design and manufacturing challenges, which can significantly slow down the progression of novel therapeutics from discovery to clinical application. Optimizing RNA sequences for critical parameters like stability, expression, and manufacturability requires extensive computational resources and specialized expertise.
Solution
Terrain Bio offers an integrated platform that accelerates RNA medicine development through AI-driven sequence design and rapid, high-quality mRNA manufacturing. The platform's AI/ML suite analyzes vast sequence spaces to optimize RNA candidates for enhanced manufacturability, stability, immunogenicity, and targetability, thereby identifying superior drug candidates. This computational design process is coupled with a proprietary manufacturing capability that delivers custom mRNA sequences at microgram to gram scales, enabling faster experimental iteration and preclinical studies. By providing both advanced sequence optimization and efficient production, Terrain Bio streamlines the early-stage development pipeline for RNA-based therapeutics.
Target Audience
The primary customers are biopharmaceutical companies and research institutions engaged in the development of RNA-based therapeutics, including those focused on mRNA vaccines and gene therapies.
Features
- AI/ML-powered sequence design suite for optimizing RNA for manufacturability, stability, expression, immunogenicity, and targetability.
- Rapid mRNA manufacturing services for custom sequences, available from microgram to gram scales.
- Catalog of pre-designed mRNA standards to facilitate efficient experimental setup.
- Proprietary algorithms for navigating complex RNA sequence space to identify optimal drug candidates.
- End-to-end workflow supporting RNA sequence discovery through to translational studies.